Streetbeat News

Regulatory

NVAX

Levi & Korsinsky has initiated an investigation into Novavax, Inc. for potential violations of federal securities laws. This follows the FDA's clinical hold on Novavax's combination influenza and Covid-19 shot and its stand-alone influenza vaccine.

Portfolio Pulse from

November 08, 2024 | 5:45 pm

RIVN

Rivian's recent financial results have led to increased caution among Wall Street analysts. The mixed quarter has prompted a reevaluation of the company's prospects, especially in light of potential policy changes under a future Trump administration.

Portfolio Pulse from

November 08, 2024 | 5:30 pm

ORA

Ormat Technologies, a leader in geothermal power, has stable revenue growth and plans to expand capacity significantly by FY26. However, the company faces risks from increased debt and potential policy changes, which may impact its valuation.

Portfolio Pulse from

November 08, 2024 | 5:00 pm

IVV

The U.S. Presidential elections and a recent Fed rate cut have led to an optimistic forecast for the S&P 500, making certain ETFs appealing for investment.

Portfolio Pulse from

November 08, 2024 | 4:30 pm

JD

JD.com stock fell as investors considered the impact of Trump's election win. Trump's proposed 60% tariffs on Chinese goods could affect Chinese exports to the U.S. JD.com's U.S. exposure is minimal, limited to logistics for Chinese companies entering the U.S. market.

Portfolio Pulse from

November 08, 2024 | 4:30 pm

XLK

XLK is expected to continue its upward trend in the short term due to Trump's potential re-election and Powell's dovish monetary stance. However, rising T-Note yields and potential inflation risks pose challenges for the future.

Portfolio Pulse from

November 08, 2024 | 4:30 pm

PNPL

Pineapple Energy shareholders have approved a change in the company's name to SUNation Energy, Inc. and its incorporation to Delaware.

Portfolio Pulse from

November 08, 2024 | 4:30 pm

ARKK

NVDA

Nvidia has been added to the Dow Jones Industrial Average, while the S&P 500 is on track for its best week of the year following a rally driven by Trump's policies. The ARK Innovation ETF surged 11.6% on expectations of favorable regulations under Trump. The article discusses market trends affecting the Nasdaq, S&P 500, and leading tech stocks.

Portfolio Pulse from

November 08, 2024 | 3:45 pm

MYGN

Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. (MYGN) for potential federal securities law violations. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test from January 2025.

Portfolio Pulse from

November 08, 2024 | 3:30 pm

PACS

The Schall Law Firm is investigating PACS Group, Inc. for potential securities law violations, alleging the company made false and misleading statements.

Portfolio Pulse from

November 08, 2024 | 3:30 pm